375 related articles for article (PubMed ID: 8084431)
1. [Pulmonary involvement in sclerodermia].
Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
[TBL] [Abstract][Full Text] [Related]
3. Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosis.
De Santis M; Bosello S; La Torre G; Capuano A; Tolusso B; Pagliari G; Pistelli R; Danza FM; Zoli A; Ferraccioli G
Respir Res; 2005 Aug; 6(1):96. PubMed ID: 16107215
[TBL] [Abstract][Full Text] [Related]
4. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
5. [Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings].
Salaffi F; Carotti M; Baldelli S; Bichi Secchi E; Manganelli P; Subiaco S; Salvolini L
Radiol Med; 1999; 97(1-2):33-41. PubMed ID: 10319097
[TBL] [Abstract][Full Text] [Related]
6. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
[TBL] [Abstract][Full Text] [Related]
7. Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.
Owens GR; Paradis IL; Gryzan S; Medsger TA; Follansbee WP; Klein HA; Dauber JH
J Lab Clin Med; 1986 Mar; 107(3):253-60. PubMed ID: 3950467
[TBL] [Abstract][Full Text] [Related]
8. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary functions in children with progressive systemic sclerosis.
Garty BZ; Athreya BH; Wilmott R; Scarpa N; Doughty R; Douglas SD
Pediatrics; 1991 Dec; 88(6):1161-7. PubMed ID: 1956732
[TBL] [Abstract][Full Text] [Related]
10. Induced sputum as a tool for early detection of airway inflammation in connective diseases-related lung involvement.
Vatrella A; Bocchino M; Perna F; Scarpa R; Galati D; Spina S; Pelaia G; Cazzola M; Sanduzzi A
Respir Med; 2007 Jul; 101(7):1383-9. PubMed ID: 17369033
[TBL] [Abstract][Full Text] [Related]
11. High resolution computed tomography in early scleroderma lung disease.
Warrick JH; Bhalla M; Schabel SI; Silver RM
J Rheumatol; 1991 Oct; 18(10):1520-8. PubMed ID: 1765976
[TBL] [Abstract][Full Text] [Related]
12. [New knowledge on the diagnosis and prognosis of interstitial lung disease in scleroderma].
König G; Behr J; Luderschmidt C
Z Rheumatol; 1990; 49(5):279-83. PubMed ID: 2080684
[TBL] [Abstract][Full Text] [Related]
13. Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis.
Clements PJ; Goldin JG; Kleerup EC; Furst DE; Elashoff RM; Tashkin DP; Roth MD
Arthritis Rheum; 2004 Jun; 50(6):1909-17. PubMed ID: 15188367
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between bronchoalveolar lavage and lung function in patients with systemic sclerosis and rheumatoid arthritis].
Pejcić T; Stanković I; Rancić M; Djordjević I; Ristić L; Vojinović J
Srp Arh Celok Lek; 2005 Dec; 133 Suppl 2():129-33. PubMed ID: 16535997
[TBL] [Abstract][Full Text] [Related]
15. Lung involvement in systemic sclerosis.
Silver RM; Miller KS
Rheum Dis Clin North Am; 1990 Feb; 16(1):199-216. PubMed ID: 2406808
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease.
Várai G; Earle L; Jimenez SA; Steiner RM; Varga J
J Rheumatol; 1998 Jul; 25(7):1325-9. PubMed ID: 9676764
[TBL] [Abstract][Full Text] [Related]
17. Early assessment of pulmonary involvement in limited scleroderma. A case report.
Unsal E; Kilinç O; Kargi A; Necla T
Turk J Pediatr; 1998; 40(4):603-8. PubMed ID: 10028872
[TBL] [Abstract][Full Text] [Related]
18. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
[TBL] [Abstract][Full Text] [Related]
19. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis.
Colaci M; Sebastiani M; Giuggioli D; Manfredi A; Spagnolo P; Luppi F; Richeldi L; Ferri C
Scand J Rheumatol; 2010 Mar; 39(2):155-9. PubMed ID: 20059446
[TBL] [Abstract][Full Text] [Related]
20. The presence of Sjögren's syndrome is a major determinant of the pattern of interstitial lung disease in scleroderma and other connective tissue diseases.
Breit SN; Cairns D; Szentirmay A; Callaghan T; Murray D; Wacher T; Gibson PG; Marks G; Bryant DH; Yeates M
J Rheumatol; 1989 Aug; 16(8):1043-9. PubMed ID: 2585401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
